Atypical antipsychotic

Schizophrenia is described by the National Institute of Mental Health as “a chronic, severe, and disabling brain disorder that has affected people throughout history” (n.d.). The most recognizable symptoms of schizophrenia are hallucinations and delusions. Hallucinations involve experiencing sensory stimulation (hearing, seeing, feeling, etc.) when there is no stimulus present. Delusions are false beliefs. Common types of delusions experienced by people with schizophrenia are delusions of persecution

An additional benefit of typical antipsychotics is its efficacy in alleviation of symptoms. Typical antipsychotics due have relative efficacy in reducing many of the hallmark symptoms of psychosis and schizophrenia (Lee, Wu, Habil, Dyachkova & Lee, 2006). Tandon & Wolfgangfleischhacker (2005) report that positive symptoms that typical antipsychotics are at least as effective in reducing compared to the newly reformed atypical antipsychotics include, “delusional thinking, hallucinatory

personality disorder that requires they must take antipsychotic drugs to remain stable. There are different types of antipsychotics like typical and atypical. Typical antipsychotics are classified as the first generation of antipyschotics. The atypical antipsychotics, the second generation, are reported to be safer than the typical antipsychotics because they are the newer form of antipsychotic medication. Even though they are reported to be

2013). Antipsychotic drugs are the primary use of treatment for schizophrenic disorders (Kane, 1987). Some of the common used psychotropic medications used to treat schizophrenia are: haloperidol, risperidone, aripiprazole, olanzapine, trifluoperazine, perphenazine, quetiapine, thioridazine, chlorpromazine, and clozapine. Antipsychotics like FGAs and SGAs are can be administered orally, in the form of a pill or liquid, or intravenously, by injections. Like with oral forms of antipsychotics, injections

The unlikely route from inflammation to antipsychotics The drug development journey leading to olanzapine (Zyprexa) reaching the market did not always follow the steps of rational drug design. Inspired by the first antipsychotic drugs, it took a while from the first discovery of antipsychotic drugs until Zyprexa was developed. The first antipsychotics were come across largely by chance. They were not specifically tailored to a relevant biological effector as rational drug design promotes. Even

Invokana Invokana (canagliflozin) is an oral diabetic medication used to help control blood sugar levels in type 2 diabetics. Type 2 diabetes is a condition, usually with an onset in adulthood, in which the body cannot make enough insulin. Canagliflozin works with the kidneys to help get rid of glucose from the bloodstream. (drugs.com, 2015) It is suggested that with a healthy diet and adequate exercise this medication has the ability to control type 2 diabetes. Invokana was developed by Mitsubishi

The Effects of Antipsychotic Medications on Schizophrenic Patients Introduction Clinical research trials can be defined as tests of new medications or devices on human participant subjects. Clinical trial sites participate in operations by which they recruit patients that may be eligible in their studies, and conduct such tests on them. I chose to observe patients diagnosed with schizophrenia participating in clinical research trials at the Neuropsychiatric Research Center of Orange County

are non-compliant with drugs because they are in denial; they think the meds aren't helping or they can't tolerate the side-effects. A good place to start is to gather information and formulate a working knowledge of antipsychotic drugs. Treating Schizophrenia with Antipsychotic Drugs Clozapine (Clozaril®, has proven the most effective of the anti-schizophrenia drugs. However, it can present with the most severe side-effects. Clozapine can cause a powerful reduction of white cells,

Disorganized schizophrenia, also known as Hebephrenic schizophrenia, is among the subtypes of schizophrenia. It is a chronic and difficult condition that includes disjointed and irrational cognitive behaviors, along with purposeless actions. This type is considered severe because of how it impacts the individual’s abilities to participate in daily activities, including self care. Causes The cause of this condition is not known, but there has been studies of a specific gene referred to as the “schizophrenia

(Tsuang et al., 2011, p. 94). Neuroleptics or antipsychotics are known to, “block dopamine D2 receptors, and this is believed to be crucial to their antipsychotic action” (McKenna & Mortimer, 2010, p. 33). Antipsychotics are labeled under two categories, “Typical” or “First- generation antipsychotics” (FGAs) and “Atypical” or “Second- generation antipsychotics” (SGAs). According to Marin, Escobar, and World Scientific (2013), “The selection of an antipsychotic for the initial treatment of schizophrenia